Studies indicate that PFAS exposure can activate inflammasomes in bronchial epithelial cells, leading to the release of pro-inflammatory cytokines (IL-1β, IL-18, and IL-33) and airway hyperresponsiveness [46]. This evidence concerns the gene IL1B and airway hyperresponsiveness.